SNTI Stock Analysis: Buy, Sell, or Hold?
SNTI - Senti Biosciences, Inc. Common Stock
$1.07
0.01 (0.94%)
▲
5d:
+0.0%
30d:
+8.76%
90d:
+27.55%
BUY
MODERATE Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 06, 2026
Get Alerted When SNTI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: SNTI shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: SNTI shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: SNTI is currently trading at $1.07, which is considered extended relative to its 30-day fair value range of $0.94 to $1.05.
Technical Outlook: Technically, SNTI is showing sideways momentum. The price is approaching resistance at $1.05. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: SNTI has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $13.00 (+1115.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, SNTI is showing sideways momentum. The price is approaching resistance at $1.05. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: SNTI has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $13.00 (+1115.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$0.94 -
$1.05
Company Quality Score
60/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
63.2%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 1115.0% below Wall St target ($13.00)
Trading Range Analysis
30-Day Trading Range
$0.94 -
$1.05
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$0.91
Resistance Level
$1.05
Current Trend
Sideways
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.13
Wall Street Target
$13.00
(+1115.0%)
Revenue Growth (YoY)
-100.0%
Share & Embed Analysis
Last updated: July 03, 2026 1:47 AM ET
Data refreshes hourly during market hours. Next update: 2:47 AM
Data refreshes hourly during market hours. Next update: 2:47 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SNTI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$412 | 59 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$197 | 54 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 63 BUY |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 62 BUY |
